Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fiboflapon add-on to FP/SAL in uncontrolled asthma
NCT01248975Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of fiboflapon in asthma (3 arms), sponsored by GSK. Primary endpoint: Trough Forced Expiratory Volume in 1 Second at 6 weeks. Started Dec 2010; status: completed.
02
Drugs
fiboflapon
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01248975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01248975.